Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Biocryst Pharmaceuticals Inc’

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Venrock Healthcare Capital Partners Discloses 7.1% Stake in Biocryst Pharmaceuticals Inc (BCRX)

Anders Hove and Bong Koh‘s VHCP Management owns a new position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), as a new filing with the US Securities......(read more)
David E. Shaw of D.E. Shaw

D. E. Shaw & Co Raises Exposure to Biocryst Pharmaceuticals Inc (BCRX)

D. E. Shaw & Co, founded by billionaire David E. Shaw, has reported its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) via a 13G filing......(read more)